Global Peritoneal Dialysis Market Is Driven By The Increasing Prevalence Of The End-Stage Renal Disease

In medicine, dialysis is the procedure of eliminating excess toxins, water, and unnecessary substances found in the blood of human beings, whose kidneys unable to perform these functionalities naturally. This is called as renal replacement therapy. Dialysis therapy is used for those patients suffering the rapidly developing loss of kidney functionality, which is called as acute kidney injury, or gradually falling functionality of kidney (Stage 5 chronic kidney disease). Dialysis is used as a provisional step in acute kidney injury or among those whoever waiting for a transplant of kidney and it serves as a permanent measure for those for whom kidney transplant is not specified or not possible.

Peritoneal dialysis (PD) is a kind of dialysis that uses peritoneum in an individual’s abdomen as the membrane through which liquid and dissolved elements are replaced with the blood. This method is used to eliminate the additional liquid, repair electrolyte issues, and remove toxins from those patient’s suffering from kidney failure disease. Peritoneal dialysis provides better results as compared to hemodialysis during the initial years.

Increasing prevalence of end-stage renal disease is one of the major aspect driving growth of the peritoneal dialysis market. In addition, growing geriatric population across the globe, which is more prone to chronic diseases such as diabetes and may generate the demand for dialysis therapy, and support the revenue growth of the global market. In addition, increasing awareness regarding advanced treatments among developed as well as developing countries and spending on healthcare services are some other aspects propelling growth of the peritoneal dialysis market.

However, the risk associated with peritoneal dialysis including infection, peritonitis, weight gain, etc. is a major aspect which may adversely impact on the demand and challenge growth of peritoneal dialysis market.

The type of peritoneal dialysis includes a peritoneal dialysis machine and a peritoneal dialysis solution.

The application of peritoneal dialysis can be categorized as automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD). Automated peritoneal dialysis(APD) is home-based dialysis treatment, where a machine is called as a cycler which will change the dialysate solution during the night, typically when patients are asleep. This means that patients must be connected to the machine for approximately 8 to 10 hours. The major benefits offered by the APD are:

• Patients can carry out the treatment themselves as per their comfort and at their own homes.
• No need to travel to the dialysis centers
• More flexibility to better fit dialysis as per their lifestyle
• Painless and needle-free procedure

Continuous ambulatory peritoneal dialysis (CAPD) is most preferred peritoneal dialysis, due to its benefits including lower in cost, portability, and machine-less procedure.

Growth of peritoneal dialysis market in Asia Pacific can be attributed to the rising prevalence of the end-stage renal disease. In addition, a strong base of population, rising demand for home-based dialysis treatment, the rapid growth of the healthcare infrastructure, and high demand for technologically advanced peritoneal dialysis devices. North America is dominating the peritoneal dialysis market which can be attributed to high awareness regarding advanced automated peritoneal dialysis technique. In addition, well-established healthcare sector and growing prevalence of ESRD are some other aspects fueling growth of the peritoneal dialysis market in this region.

The key players operating in the global market are TOTO, Showa Denko, ISK, BASF, JSR CORP., KRONOS, KHI, Lister, Aoinn Environmental, Dongguan Tomorrow, Chem-Well Tech, and Kon Corporation.